BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35060539)

  • 1. Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean.
    Yamamoto-Furusho JK; Parra-Holguín NN; Juliao-Baños F; Puentes F; López R; Bosques-Padilla F; Torres EA; Nieves-Jimenéz H; Veitia-Velásquez GR; Jara-Alba ML; Bautista S; Piñol-Jimenez FN; Salgado-Rosado P; Villa-Ovalles KC; Abreu-Martinez YA; Borges Z; Davila-Bedoya S; Otoya-Moreno G; Iadé-Vergara B;
    Medicine (Baltimore); 2022 Jan; 101(3):e28624. PubMed ID: 35060539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review.
    Kotze PG; Underwood FE; Damião AOMC; Ferraz JGP; Saad-Hossne R; Toro M; Iade B; Bosques-Padilla F; Teixeira FV; Juliao-Banos F; Simian D; Ghosh S; Panaccione R; Ng SC; Kaplan GG
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):304-312. PubMed ID: 31252191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
    Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
    Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America.
    Balderramo D; Quaresma AB; Olivera PA; Savio MC; Villamil MPG; Panaccione R; Ng SC; Kaplan GG; Kotze PG
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):263-272. PubMed ID: 38340754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic epidemiology of inflammatory bowel disease in Puerto Rico.
    Appleyard CB; Hernández G; Rios-Bedoya CF
    Inflamm Bowel Dis; 2004 Mar; 10(2):106-11. PubMed ID: 15168809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU.
    Yamamoto-Furusho JK; Andrade D; Barahona J; Bautista S; Bosques-Padilla F; de Paula J; Galiano MT; Iade B; Juliao-Baños F; Otoya G; Steinwurz F; Torres E; Veitia G; Barreiro-de Acosta M
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(1):89-102. PubMed ID: 34866040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
    Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.
    Massuger W; Moore GTC; Andrews JM; Kilkenny MF; Reyneke M; Knowles S; Purcell L; Alex G; Buckton S; Page AT; Stocks N; Cameron D; Manglaviti F; Pavli P
    Intern Med J; 2019 Jul; 49(7):859-866. PubMed ID: 30525299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.
    King JA; Underwood FE; Panaccione N; Quan J; Windsor JW; Kotze PG; Ng SC; Ghosh S; Lakatos PL; Jess T; Panaccione R; Seow CH; Ben-Horin S; Burisch J; Colombel JF; Loftus EV; Gearry R; Halfvarson J; Kaplan GG
    Lancet Gastroenterol Hepatol; 2019 Apr; 4(4):287-295. PubMed ID: 30765267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
    Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
    Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience.
    Kim BJ; Song SM; Kim KM; Lee YJ; Rhee KW; Jang JY; Park SJ; Yoon CH
    Dig Dis Sci; 2010 Jul; 55(7):1989-95. PubMed ID: 19763825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina.
    Balderramo D; Trakal J; Herrera Najum P; Vivas M; Gonzalez R; Benavidez A; López Villa D; Daino D; Raiden K; Germán A; Corzo MA; Ponce de León J; Ferrer L; Germán C; Bálzola S; Idoeta A; Zárate F; Defagó MR;
    Dig Liver Dis; 2021 Jul; 53(7):852-857. PubMed ID: 33531211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE WESTERN REGION OF MINAS GERAIS STATE.
    Martins KR; Araújo JM; Cruz ÁC; Luiz-Ferreira A
    Arq Gastroenterol; 2021; 58(3):377-383. PubMed ID: 34705974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease in Korea: epidemiology and pathophysiology.
    Lee JW; Eun CS
    Korean J Intern Med; 2022 Sep; 37(5):885-894. PubMed ID: 35902371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.